Literature DB >> 12115617

The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function.

Jing Wang1, Amy Foster, Robert Chin, Ping Yu, Yonglian Sun, Yang Wang, Klaus Pfeffer, Yang-Xin Fu.   

Abstract

Highly organized lymphoid structures provide the intricate microenvironment essential for the mediation of the effective immune responses. Compared with lymphotoxin beta knockout mice (LTbeta-/-), LTbeta receptor knockout (LTbetaR-/-) mice present with more severely disorganized splenic structures, suggesting the potential involvement of another ligand. LIGHT, a newly identified TNF family member, is a costimulatory molecule for T cells and binds to LTbetaR and herpes virus entry mediator (HVEM) in vitro. Here, we show that the complementation of LTalpha-/- mice with a LIGHT transgene (LIGHT Tg/LTalpha-/-) leads to the restoration of secondary lymphoid tissue chemokine and T/B cell zone segregation. LIGHT Tg/LTalpha-/- mice also preserve dendritic cells, follicular dendritic cell networks, and germinal centers, though not the marginal zone. Consequently, IgG responses to soluble, but not particulate, antigens are restored, confirming the role of primary follicle and marginal zone in the responses to soluble and particulate antigens. The failure of the LIGHT transgene to rescue the defective splenic structures in LTbetaR-/- mice demonstrates that LIGHT can interact with LTbetaR in vivo. More severely disorganized splenic structures developed after blockade of endogenous LIGHT in LTbeta-/- mice. These findings uncover the potential interaction between LIGHT and one of its receptors, LTbetaR, in supporting even in the absence of LT the development and maintenance of lymphoid microenvironment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115617     DOI: 10.1002/1521-4141(200207)32:7<1969::AID-IMMU1969>3.0.CO;2-M

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

Review 1.  The role of LIGHT in T cell-mediated immunity.

Authors:  Jing Wang; Yang-Xin Fu
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 2.  Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.

Authors:  Thomas W Spahn; Hans-Pietro Eugster; Adriano Fontana; Wolfram Domschke; Torsten Kucharzik
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 3.  Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners.

Authors:  Marcos W Steinberg; Jr-Wen Shui; Carl F Ware; Mitchell Kronenberg
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

Review 4.  Development of secondary lymphoid organs.

Authors:  Troy D Randall; Damian M Carragher; Javier Rangel-Moreno
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 5.  Keystones in lymph node development.

Authors:  Katrin S Blum; Reinhard Pabst
Journal:  J Anat       Date:  2006-11       Impact factor: 2.610

Review 6.  Targeting and utilizing primary tumors as live vaccines: changing strategies.

Authors:  Xuanming Yang; Eric D Mortenson; Yang-Xin Fu
Journal:  Cell Mol Immunol       Date:  2011-11-21       Impact factor: 11.530

7.  LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro-inflammatory cytokines and MMP-9 in macrophages.

Authors:  Won-Jung Kim; Yoon-Joong Kang; Eun-Mi Koh; Kwang-Sung Ahn; Hoon-Suk Cha; Won-Ha Lee
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

8.  Excess LIGHT contributes to placental impairment, increased secretion of vasoactive factors, hypertension, and proteinuria in preeclampsia.

Authors:  Wei Wang; Nicholas F Parchim; Takayuki Iriyama; Renna Luo; Cheng Zhao; Chen Liu; Roxanna A Irani; Weiru Zhang; Chen Ning; Yujin Zhang; Sean C Blackwell; Lieping Chen; Lijian Tao; M John Hicks; Rodney E Kellems; Yang Xia
Journal:  Hypertension       Date:  2013-12-09       Impact factor: 10.190

Review 9.  Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment.

Authors:  Aliyah M Weinstein; Walter J Storkus
Journal:  Adv Cancer Res       Date:  2015-05-05       Impact factor: 6.242

10.  Redundancy in tumor necrosis factor (TNF) and lymphotoxin (LT) signaling in vivo: mice with inactivation of the entire TNF/LT locus versus single-knockout mice.

Authors:  Dmitry V Kuprash; Marat B Alimzhanov; Alexei V Tumanov; Sergei I Grivennikov; Alexander N Shakhov; Ludmila N Drutskaya; Michael W Marino; Regina L Turetskaya; Arthur O Anderson; Klaus Rajewsky; Klaus Pfeffer; Sergei A Nedospasov
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.